23 / 38
Palbociclib
PALLAS
low-high risk
4000
PENELOPE-B
Post-neoadjuvant C
1250
Ribociclib
EarLEE-1
high risk
2000
EarLEE-2
intermediate risk
4000
Abemaciclib
MONARCH-E
High risk
3580
CDK4/6 inhibitor adjuvant trials
|
|
23 / 38
23 / 38
Palbociclib
PALLAS
low-high risk
4000
PENELOPE-B
Post-neoadjuvant C
1250
Ribociclib
EarLEE-1
high risk
2000
EarLEE-2
intermediate risk
4000
Abemaciclib
MONARCH-E
High risk
3580
CDK4/6 inhibitor adjuvant trials